Canaan VII
Canaan VII is an early-stage venture capital fund managed by Canaan Partners, a global firm established in 1987 and based in San Francisco, California. The fund focuses on investing in the software and technology, media, and telecommunications (TMT) sectors within the United States. Canaan Partners manages a diverse portfolio with over 190 exits and has invested in more than 250 companies across various industries, including fintech, healthcare, and digital health. The firm employs a team of experienced investment professionals who seek to support visionary entrepreneurs with innovative ideas, providing capital ranging from $1 million to $20 million across different stages of development. With approximately $5 billion under management across multiple funds, Canaan Partners continues to play a significant role in fostering growth within the technology and healthcare landscapes.
MindTickle Interactive Media Pvt Ltd. provides a social learning platform for organizations and corporations in various industries. Its platform enables businesses, trainers, and individuals to transform their existing online content into an interactive learning experience; use game mechanics, such as points, medals, badges, and leader boards to increase learner motivation and engagement; create learner engagement and peer-to-peer learning by leveraging the power of social mechanics; and measure and track the effectiveness Web-based training programs through real-time charts and dashboards. The company’s platform is used for new hire orientation, policy refreshment, and employee engagement applications. MindTickle Interactive Media Pvt Ltd. was founded in 2011 and is based in Pune, India.
Tyra Biosciences is a clinical-stage biotechnology company based in Carlsbad, California, focused on developing small molecule therapies for cancer treatment. Founded in 2018, the company aims to address drug resistance in oncology by targeting specific pathways associated with acquired resistance. Tyra Biosciences employs its proprietary precision medicine platform, SNÅP, to facilitate rapid drug design through molecular snapshots, enabling the prediction of genetic alterations that may lead to resistance against existing therapies. The company's lead product candidate, TYRA 300, is an FGFR3 selective inhibitor, primarily aimed at treating patients with metastatic urothelial carcinoma of the bladder and urinary tract. Through innovative approaches, Tyra Biosciences seeks to create next-generation precision medicines that significantly improve treatment outcomes for cancer patients.
MindTickle Interactive Media Pvt Ltd. provides a social learning platform for organizations and corporations in various industries. Its platform enables businesses, trainers, and individuals to transform their existing online content into an interactive learning experience; use game mechanics, such as points, medals, badges, and leader boards to increase learner motivation and engagement; create learner engagement and peer-to-peer learning by leveraging the power of social mechanics; and measure and track the effectiveness Web-based training programs through real-time charts and dashboards. The company’s platform is used for new hire orientation, policy refreshment, and employee engagement applications. MindTickle Interactive Media Pvt Ltd. was founded in 2011 and is based in Pune, India.
Tyra Biosciences is a clinical-stage biotechnology company based in Carlsbad, California, focused on developing small molecule therapies for cancer treatment. Founded in 2018, the company aims to address drug resistance in oncology by targeting specific pathways associated with acquired resistance. Tyra Biosciences employs its proprietary precision medicine platform, SNÅP, to facilitate rapid drug design through molecular snapshots, enabling the prediction of genetic alterations that may lead to resistance against existing therapies. The company's lead product candidate, TYRA 300, is an FGFR3 selective inhibitor, primarily aimed at treating patients with metastatic urothelial carcinoma of the bladder and urinary tract. Through innovative approaches, Tyra Biosciences seeks to create next-generation precision medicines that significantly improve treatment outcomes for cancer patients.
MindTickle Interactive Media Pvt Ltd. provides a social learning platform for organizations and corporations in various industries. Its platform enables businesses, trainers, and individuals to transform their existing online content into an interactive learning experience; use game mechanics, such as points, medals, badges, and leader boards to increase learner motivation and engagement; create learner engagement and peer-to-peer learning by leveraging the power of social mechanics; and measure and track the effectiveness Web-based training programs through real-time charts and dashboards. The company’s platform is used for new hire orientation, policy refreshment, and employee engagement applications. MindTickle Interactive Media Pvt Ltd. was founded in 2011 and is based in Pune, India.
MindTickle Interactive Media Pvt Ltd. provides a social learning platform for organizations and corporations in various industries. Its platform enables businesses, trainers, and individuals to transform their existing online content into an interactive learning experience; use game mechanics, such as points, medals, badges, and leader boards to increase learner motivation and engagement; create learner engagement and peer-to-peer learning by leveraging the power of social mechanics; and measure and track the effectiveness Web-based training programs through real-time charts and dashboards. The company’s platform is used for new hire orientation, policy refreshment, and employee engagement applications. MindTickle Interactive Media Pvt Ltd. was founded in 2011 and is based in Pune, India.
The company is establishing collaborations with its scientific founders “to better understand whether regulatory T cells play a more prominent role in certain tumors,” he added. Although research suggests that Tregs cells play a more prominent role in creating immunosuppression in the microenvironment in some tumor types than others, “quite honestly, the data are lacking. One of the ways we’re going to differentiate the company is to understand that relationship better.
Myteam.com is the online center for amateur sports and is the world's first Internet site dedicated to serving the needs of the sports family and the entire amateur sports community - players, parents, coaches, league administrators and fans. Everyone who joins myteam.com receives a free secure, personal home page, where information is automatically updated from all his or her teams and leagues. Personal home pages stay with members season-to-season, sport-to-sport, year-to-year.